CKD-related secondary hyperparathyroidism is driven by which combination?

• A. Increased intestinal calcium absorption and high calcitriol
• B. Impaired phosphate excretion and reduced active vitamin D leading to hypocalcemia with PTH elevation
• C. Low phosphate levels
• D. Decreased PTH production

Answer: (B)

In CKD, secondary hyperparathyroidism develops because the kidneys can’t excrete phosphate effectively and can’t activate vitamin D. This combination leads to two main problems: high phosphate levels and low levels of active vitamin D (calcitriol). The excess phosphate binds calcium, causing a drop in ionized calcium (hypocalcemia). At the same time, reduced production of calcitriol means less calcium is absorbed from the gut, further lowering calcium levels. The parathyroid glands sense this hypocalcemia (and the low calcitriol influence) and respond by increasing PTH secretion, driving secondary hyperparathyroidism.

That’s why this option—impaired phosphate excretion with reduced active vitamin D leading to hypocalcemia and PTH elevation—best describes the CKD-driven process. The other ideas don’t fit: CKD typically raises phosphate, not lowers it; calcitriol is decreased, not increased; and PTH production is elevated, not decreased.